{"url_path":"/sec/asmb/13dg/2026-05-11/000110465926058623","section_key":"body","section_title":"SCHEDULE 13G body","topic":"sec","document":{"doc_type":"SCHEDULE 13G","doc_date":"2026-05-11","source_url":"https://www.sec.gov/Archives/edgar/data/1426800/0001104659-26-058623-index.html","accession_number":"0001104659-26-058623","cik":"0001426800","ticker":"ASMB","issuer_name":"ASSEMBLY BIOSCIENCES, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1426800/0001104659-26-058623-index.html","primary_entity_key":"0001426800","primary_entity_name":"ASSEMBLY BIOSCIENCES, INC."},"word_count":126,"has_tables":true,"body_markdown":"EX-99.1\n2\ntm2613652d1_ex99-1.htm\nEXHIBIT 99.1\n\n**Exhibit 99.1**\n\n****\n\n**JOINT FILING AGREEMENT**\n\nIn accordance with Rule 13d-1(k) under the Securities\nExchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a statement on Schedule\n13G (including amendments thereto) with respect to the Common Shares, par value $0.001 per share, of Assembly Biosciences, Inc., and further\nagree that this Joint Filing Agreement be included as an Exhibit to such joint filing. In evidence thereof, the undersigned hereby execute\nthis Agreement.\n\nDated: May 11, 2026\n\nParadigm BioCapital Advisors LP\n\nParadigm BioCapital Advisors GP LLC\n\nParadigm BioCapital International Fund Ltd.\n\nBy:\n/s/ David K. Kim\n\nName: David K. Kim\n\nTitle: Authorized Signatory\n\n/s/ Senai Asefaw, M.D.\n\nSenai Asefaw, M.D.\n\n****\n\n****"}